Genetic Signatures Limited (GSS.AX)

AUD 0.63

(-8.03%)

Net Debt Summary of Genetic Signatures Limited

Genetic Signatures Limited's latest annual net debt in 2024 was -35.03 Million AUD , down -114.27% from previous year.
Genetic Signatures Limited's latest quarterly net debt in 2024 FY was -35.03 Million AUD , down -114.27% from previous quarter.
Genetic Signatures Limited reported annual net debt of -16.34 Million AUD in 2023, up 55.65% from previous year.
Genetic Signatures Limited reported annual net debt of -36.86 Million AUD in 2022, down -24.03% from previous year.
Genetic Signatures Limited reported quarterly net debt of -35.03 Million AUD for 2024 FY, down -114.27% from previous quarter.
Genetic Signatures Limited reported quarterly net debt of -35.03 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Net Debt Chart of Genetic Signatures Limited (2024 - 2013)

Historical Annual Net Debt of Genetic Signatures Limited (2024 - 2013)

Year	Net Debt	Net Debt Growth
2024	-35.03 Million AUD	-114.27%
2023	-16.34 Million AUD	55.65%
2022	-36.86 Million AUD	-24.03%
2021	-29.72 Million AUD	2.34%
2020	-30.43 Million AUD	-382.18%
2019	-6.31 Million AUD	29.51%
2018	-8.95 Million AUD	32.12%
2017	-13.19 Million AUD	-414.5%
2016	-2.56 Million AUD	53.05%
2015	-5.46 Million AUD	64.58%
2014	-15.42 Million AUD	-508.36%
2013	3.77 Million AUD	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	-18.11 Million AUD	0.0%
2024 FY	-35.03 Million AUD	-114.27%
2024 Q4	-35.03 Million AUD	0.0%
2023 Q2	-26.84 Million AUD	0.0%
2023 Q4	-16.34 Million AUD	0.0%
2023 FY	-16.34 Million AUD	55.65%
2022 FY	-36.86 Million AUD	-24.03%
2022 Q4	-36.86 Million AUD	0.0%
2022 Q2	-37.27 Million AUD	0.0%
2021 FY	-29.72 Million AUD	2.34%
2021 Q4	-29.72 Million AUD	0.0%
2021 Q2	-35.7 Million AUD	0.0%
2020 Q2	-39.53 Million AUD	0.0%
2020 Q4	-30.43 Million AUD	0.0%
2020 FY	-30.43 Million AUD	-382.18%
2019 FY	-6.31 Million AUD	29.51%
2019 Q2	-8.82 Million AUD	0.0%
2019 Q4	-6.31 Million AUD	0.0%
2018 FY	-8.95 Million AUD	32.12%
2018 Q2	-11.72 Million AUD	0.0%
2018 Q4	-8.95 Million AUD	0.0%
2017 Q4	-13.19 Million AUD	0.0%
2017 Q2	-16 Million AUD	0.0%
2017 FY	-13.19 Million AUD	-414.5%
2016 Q4	-2.56 Million AUD	0.0%
2016 FY	-2.56 Million AUD	53.05%
2016 Q2	-4.31 Million AUD	0.0%
2015 Q4	-5.46 Million AUD	0.0%
2015 Q3	-5.46 Million AUD	0.0%
2015 FY	-5.46 Million AUD	64.58%
2015 Q1	- AUD	0.0%
2014 FY	-15.42 Million AUD	-508.36%
2013 FY	3.77 Million AUD	0.0%

Peer Net Debt Comparison of Genetic Signatures Limited

Name	Net Debt	Net Debt Difference
Australian Clinical Labs Limited	282.76 Million AUD	112.389%
BCAL Diagnostics Limited	-5.83 Million AUD	-500.705%
Genetic Technologies Limited	-377.06 Thousand AUD	-9190.515%
Healius Limited	1.53 Billion AUD	102.278%
Imagion Biosystems Limited	5.81 Million AUD	702.812%
Integral Diagnostics Limited	315.35 Million AUD	111.108%
INOVIQ Ltd	-8.69 Million AUD	-302.742%
Microba Life Sciences Limited	-20.49 Million AUD	-70.932%
Monash IVF Group Limited	48.23 Million AUD	172.63%
Rhythm Biosciences Limited	-545.67 Thousand AUD	-6319.767%
Sonic Healthcare Limited	3.87 Billion AUD	100.905%